Chemistry and Synthesis S1 Bioassays S4 Pharmacokinetics (PK) protocol S6
TABLE OF CONTENTS
Chemistry and Synthesis S1 Bioassays S4 Pharmacokinetics (PK) protocol S6
Chemistry
All reagents and solvents were used as received from commercial sources. 1 H NMR spectra were recorded on a Bruker, Avance 400 Spectrometer 400 MHz nuclear magnetic resonance spectrometer. 1 H NMR spectra were recorded in CDCl 3 , CD 3 OD, or DMSO-d 6 , and chemical shifts are reported relative to a TMS internal standard to the residual solvent peak (abbreviation in spectra: s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, m = multiplet). UPLC analysis was performed using an Acquity UPLC BEH○R C18 (1.7 µm, 2.1 × 100 mm) with 5% acetonitrile in water (0-1 min), 15-90% acetonitrile in water (1-8.5 min), 90% acetonitrile (8.5-10 min), with both solvents containing 0.1% formic acid as a modifier with a flow of 0.4 mL/min; and UV detection at 230 nm. Purification by flash chromatography was carried out using either Zeochem C-gel 560 (0.060-0.200 mm, Zeochem) or MPLC with a Teledyne Isco CombiFlash Rf with RediSep Flash columns using a gradient of ethyl acetate in n-hexanes or methanol in CH 2 Cl 2 , or similar instrument or reverse phase preparative HPLC. TLC analysis was performed on silica gel 60 F 254 plates.
S2
Liquid chromatography mass spectra (LCMS) were obtained on Agilent technologies G6120B using electrospray ionization (ESI). LCMS analysis was performed using a Eclipse Plus C18 (3.5 µm, 4.6 × 100 mm) with 46-91% acetonitrile in water (0-2.5 min), 91% acetonitrile (2.5-4.0 min), 91-46% acetonitrile in water (4.0-4.5 min) and staying at 46% acetonitrle (4.5-5.0 min), with both solvents containing 0.1% formic acid as modifier with a flow of 1.5 mL/min and UV detection at 230 nm. Purity of all final analogues for biological testing were confirmed to be >95% as determined by UPLC analysis and inspection of NMR spectra. To a mixture of 3-bromo-5-hydroxy-benzoic acid methyl ester (18.5 g, 0.08 mol), (R)-(-)-1methoxy-2-propanol (10.2 g, 0.11 mol) and triphenylphosphine ( 1.4. Synthesis of 3-(3-amino-phenylethynyl)-5-(2-methoxy-(1S)-methyl-ethoxy)-N-(1methyl-1H-pyrazol-3-yl)-benzamide (19) To a solution of 10 (700 mg, 1.90 mmol) in tetrabutylammonium fluoride trihydrate ( 
Synthesis of 3-Bromo

Bioassays
For experiments involving the use of animals, all procedures were carried out in accordance with the guidelines of the Institutional Animal Care and Use Committee of Yuhan Research Institute.
Glucokinase enzymatic assay
An enzymatic glucokinase assay using purified recombinant human pancreatic glucokinase was used to evaluate the compounds. Glucokinase activity was assessed spectrometrically by a coupled reaction with glucose-6-phosphate dehydrogenase S5 (G6PDH). 34 Briefly, GK catalyzes glucose phosphorylation to generate glucose-6-P, which is oxidized by G6PDH with the concomitant reduction of NADPH. The resultant NADPH is then monitored via an increase in the rate of absorbance at 340 nm using a plate reader (Spectra-Max 384 plus, Molecular Devices, CA, USA). All compounds were prepared in DMSO and the assay was performed in 96-well plates in a final volume of 100 µL containing 25 mM HEPES pH 7.4, 10 mM glucose, 25 mM KCl, 1 mM MgCl 2 , 1 mM DTT, 1 mM ATP, 1 mM NADP, 2.5 U/mL G6PDH, 1 mM glucose, 0.1 µg glucokinase, and the test compounds.
The fold activation of the enzyme was assessed by comparing with controls (GK activation in DMSO only was considered as 100%). For EC 50 determination, 12 different concentrations of the compounds were tested in the assay, and the fold changes in activity versus controls were fitted to a sigmoidal curve using a dose-response variable slope model in GraphPad Prism 5.
Glucose uptake in rat primary hepatocytes
Hepatocytes were isolated by in situ liver perfusion with collagenase. The viability of isolated hepatocytes were determined to be over 85% via Trypan blue exclusion assay. Cells were suspended in MEM supplemented with 10% fetal bovine serum (v/v), 100 U/mL penicillin, and 100 µg/mL streptomycin. 1 × 10 6 cells/well were planted onto collagen 1coated 12-well plates. After 36 h incubation (37 °C; 5% CO 2 /95% air v/v) to allow cell attachment, the medium was replaced with serum-free media for a further 12 h culture. 2-Deoxy-D-[ 3 H]-glucose uptake was assessed in cultured hepatocytes. Cells were washed and incubated in serum-free MEM containing 5.5 mM glucose, and 2 µCi/mL 2-deoxy-D-[ 3 H]glucose with or without the test compounds for 4 h. The reaction was terminated and washed three times with ice-cold phosphate buffered saline (PBS), and then cells were lysed with 0.1 N NaOH. Portions of cell lysates were used for scintillation counting, and the results were recorded as increased percentage versus control.
